Advertisement

Topics

Sequencing Questions Remain in Prostate Cancer Paradigm

09:40 EST 13 Feb 2018 | OncLive

Christopher Sweeney, MBBS, discusses the role of abiraterone for patients with hormone-sensitive prostate cancer, and what physicians should consider when choosing between abiraterone and docetaxel.

Original Article: Sequencing Questions Remain in Prostate Cancer Paradigm

NEXT ARTICLE

More From BioPortfolio on "Sequencing Questions Remain in Prostate Cancer Paradigm"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...